Literature DB >> 30345421

Further clinical advancement of dendritic cell vaccination against ovarian cancer.

Lauren C Morehead1, Martin J Cannon1.   

Abstract

Entities:  

Year:  2018        PMID: 30345421      PMCID: PMC6192055          DOI: 10.21037/arh.2018.08.02

Source DB:  PubMed          Journal:  Ann Res Hosp        ISSN: 2523-0743


× No keyword cloud information.
  14 in total

1.  Indoleamine 2,3-dioxygenase serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells.

Authors:  Aikou Okamoto; Takashi Nikaido; Kazunori Ochiai; Satoshi Takakura; Misato Saito; Yuko Aoki; Nobuya Ishii; Nozomu Yanaihara; Kyosuke Yamada; Osamu Takikawa; Rie Kawaguchi; Seiji Isonishi; Tadao Tanaka; Mitsuyoshi Urashima
Journal:  Clin Cancer Res       Date:  2005-08-15       Impact factor: 12.531

Review 2.  Integrating Next-Generation Dendritic Cell Vaccines into the Current Cancer Immunotherapy Landscape.

Authors:  Abhishek D Garg; Pierre G Coulie; Benoit J Van den Eynde; Patrizia Agostinis
Journal:  Trends Immunol       Date:  2017-06-10       Impact factor: 16.687

3.  Safety and Antitumor Activity of Anti-PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer.

Authors:  Junzo Hamanishi; Masaki Mandai; Takafumi Ikeda; Manabu Minami; Atsushi Kawaguchi; Toshinori Murayama; Masashi Kanai; Yukiko Mori; Shigemi Matsumoto; Shunsuke Chikuma; Noriomi Matsumura; Kaoru Abiko; Tsukasa Baba; Ken Yamaguchi; Akihiko Ueda; Yuko Hosoe; Satoshi Morita; Masayuki Yokode; Akira Shimizu; Tasuku Honjo; Ikuo Konishi
Journal:  J Clin Oncol       Date:  2015-09-08       Impact factor: 44.544

Review 4.  Polarized dendritic cells as cancer vaccines: directing effector-type T cells to tumors.

Authors:  Pawel Kalinski; Hideho Okada
Journal:  Semin Immunol       Date:  2010-04-20       Impact factor: 11.130

5.  Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival.

Authors:  Tyler J Curiel; George Coukos; Linhua Zou; Xavier Alvarez; Pui Cheng; Peter Mottram; Melina Evdemon-Hogan; Jose R Conejo-Garcia; Lin Zhang; Matthew Burow; Yun Zhu; Shuang Wei; Ilona Kryczek; Ben Daniel; Alan Gordon; Leann Myers; Andrew Lackner; Mary L Disis; Keith L Knutson; Lieping Chen; Weiping Zou
Journal:  Nat Med       Date:  2004-08-22       Impact factor: 53.440

6.  Comparison of clinical grade type 1 polarized and standard matured dendritic cells for cancer immunotherapy.

Authors:  Morten Hansen; Gertrud Malene Hjortø; Marco Donia; Özcan Met; Niels Bent Larsen; Mads Hald Andersen; Per thor Straten; Inge Marie Svane
Journal:  Vaccine       Date:  2012-11-29       Impact factor: 3.641

Review 7.  Re-Emergence of Dendritic Cell Vaccines for Cancer Treatment.

Authors:  Mansi Saxena; Nina Bhardwaj
Journal:  Trends Cancer       Date:  2018-02

8.  Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells.

Authors:  F J Hsu; C Benike; F Fagnoni; T M Liles; D Czerwinski; B Taidi; E G Engleman; R Levy
Journal:  Nat Med       Date:  1996-01       Impact factor: 53.440

9.  Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer.

Authors:  Janos L Tanyi; Sara Bobisse; Eran Ophir; Sandra Tuyaerts; Annalisa Roberti; Raphael Genolet; Petra Baumgartner; Brian J Stevenson; Christian Iseli; Denarda Dangaj; Brian Czerniecki; Aikaterini Semilietof; Julien Racle; Alexandra Michel; Ioannis Xenarios; Cheryl Chiang; Dimitri S Monos; Drew A Torigian; Harvey L Nisenbaum; Olivier Michielin; Carl H June; Bruce L Levine; Daniel J Powell; David Gfeller; Rosemarie Mick; Urania Dafni; Vincent Zoete; Alexandre Harari; George Coukos; Lana E Kandalaft
Journal:  Sci Transl Med       Date:  2018-04-11       Impact factor: 17.956

10.  Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients.

Authors:  Duane A Mitchell; Kristen A Batich; Michael D Gunn; Min-Nung Huang; Luis Sanchez-Perez; Smita K Nair; Kendra L Congdon; Elizabeth A Reap; Gary E Archer; Annick Desjardins; Allan H Friedman; Henry S Friedman; James E Herndon; April Coan; Roger E McLendon; David A Reardon; James J Vredenburgh; Darell D Bigner; John H Sampson
Journal:  Nature       Date:  2015-03-11       Impact factor: 49.962

View more
  1 in total

Review 1.  The Effect of the Tumor Microenvironment and Tumor-Derived Metabolites on Dendritic Cell Function.

Authors:  Jun-Ho Lee; So-Yeon Choi; Nam-Chul Jung; Jie-Young Song; Han Geuk Seo; Hyun Soo Lee; Dae-Seog Lim
Journal:  J Cancer       Date:  2020-01-01       Impact factor: 4.207

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.